SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-306287
Filing Date
2019-12-04
Accepted
2019-12-04 17:08:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d842236d424b5.htm 424B5 432884
2 GRAPHIC g842236g81t98.jpg GRAPHIC 25909
  Complete submission text file 0001193125-19-306287.txt   469651
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221911 | Film No.: 191268790
SIC: 2834 Pharmaceutical Preparations